[go: up one dir, main page]

DE2328093A1 - Peptidinhibitoren, ihre salze mit saeuren und arzneimittel - Google Patents

Peptidinhibitoren, ihre salze mit saeuren und arzneimittel

Info

Publication number
DE2328093A1
DE2328093A1 DE19732328093 DE2328093A DE2328093A1 DE 2328093 A1 DE2328093 A1 DE 2328093A1 DE 19732328093 DE19732328093 DE 19732328093 DE 2328093 A DE2328093 A DE 2328093A DE 2328093 A1 DE2328093 A1 DE 2328093A1
Authority
DE
Germany
Prior art keywords
pro
trp
pyr
arg
ile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19732328093
Other languages
German (de)
English (en)
Inventor
Miguel Angel Ondetti
Josip Pluscec
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00258714A external-priority patent/US3832337A/en
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of DE2328093A1 publication Critical patent/DE2328093A1/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • C07K5/06156Dipeptides with the first amino acid being heterocyclic and Trp-amino acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1021Tetrapeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1024Tetrapeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19732328093 1972-06-01 1973-06-01 Peptidinhibitoren, ihre salze mit saeuren und arzneimittel Pending DE2328093A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00258714A US3832337A (en) 1970-07-28 1972-06-01 Peptide enzyme inhibitors

Publications (1)

Publication Number Publication Date
DE2328093A1 true DE2328093A1 (de) 1973-12-20

Family

ID=22981808

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19732328093 Pending DE2328093A1 (de) 1972-06-01 1973-06-01 Peptidinhibitoren, ihre salze mit saeuren und arzneimittel

Country Status (3)

Country Link
CH (1) CH568964A5 (nl)
DE (1) DE2328093A1 (nl)
GB (1) GB1432249A (nl)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019829A1 (de) * 1979-05-25 1980-12-10 Brantl, Victor, Dr. med., Dipl.-Chem. Pharmakologisch aktive Peptide und deren Zusammensetzungen
EP0301639A2 (en) * 1983-05-13 1989-02-01 ENI-Ente Nazionale Idrocarburi Analogues of the bradykinin potentiating peptide BPP 5a and methods for their preparation

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019829A1 (de) * 1979-05-25 1980-12-10 Brantl, Victor, Dr. med., Dipl.-Chem. Pharmakologisch aktive Peptide und deren Zusammensetzungen
WO1980002696A1 (en) * 1979-05-25 1980-12-11 H Teschemacher Pharmacologically active peptides
US4681871A (en) * 1979-05-25 1987-07-21 Hansjorg Teschemacher Pharmacologically active peptides
EP0301639A2 (en) * 1983-05-13 1989-02-01 ENI-Ente Nazionale Idrocarburi Analogues of the bradykinin potentiating peptide BPP 5a and methods for their preparation
EP0301639A3 (en) * 1983-05-13 1989-10-18 ENI-Ente Nazionale Idrocarburi Analogues of the bradykinin potentiating peptide bpp 5a and methods for their preparation

Also Published As

Publication number Publication date
GB1432249A (en) 1976-04-14
CH568964A5 (nl) 1975-11-14

Similar Documents

Publication Publication Date Title
US3832337A (en) Peptide enzyme inhibitors
DE2616399C2 (de) Desamino-1,7-dicarbacalcitonine und Verfahren zu ihrer Herstellung
DE2617646C2 (de) Nonapeptid-amide und Decapeptid-amide mit Gonadoliberin-Wirkung, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
EP0804463A1 (de) Neurokinin (tachykinin)-antagonisten
EP0449079B1 (de) Hydantoinderivate
DD200799A5 (de) Verfahren zur herstellung von peptiden
CH615904A5 (en) Process for the preparation of L-leucine-13-motilin
CH636598A5 (de) Verfahren zur herstellung neuer psychopharmakologisch aktiver peptide.
US3770715A (en) Acth active peptides having d serine as first aminoacid from n terminus and l ornithine as11 aminoacid
US3749703A (en) Asn15-bovine thyrocalcitonin
US3743726A (en) Psychopharmacological preparation
DE2328093A1 (de) Peptidinhibitoren, ihre salze mit saeuren und arzneimittel
DE2326033C2 (de) Peptide und deren Derivate sowie diese Verbindungen enthaltende Arzneimittel mit psychopharmakologischer Wirkung
DE2327396A1 (de) Synthetisches polypeptid und verfahren zur herstellung desselben
AT389704B (de) Verfahren zur herstellung von neuen gonadoliberin-derivaten
EP0491361B1 (de) Kurze Peptide mit Insulinwirkung
NO751044L (nl)
DE2311786C2 (de) Verfahren zur Herstellung von Peptiden
US3812091A (en) D-analogs of secretin
US3738978A (en) Process for the manufacture of peptides
DE2124451A1 (de) Peptide und Arzneipräparate
DE2114300C3 (de) Octadekapeptide und Arzneipräparate
DE3537405A1 (de) Biologisch aktive penta- und heptapeptide, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
DE2327634A1 (de) Nonapeptide und verfahren zu deren herstellung
CH499497A (de) Verfahren zur Herstellung neuer Polypeptide

Legal Events

Date Code Title Description
OHA Expiration of time for request for examination